Corbus Pharmaceuticals Holdings, Inc. CRBP
7.14
(0.31)
(4.16%)
as of 25 Sep
- Market cap
- $144.1M
- P/E
- 0.0×
Follow CRBP
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
6.11 | 7.92 | 7.64 | 5.49 | |
Current Ratio |
6.31 | 8.07 | 7.92 | 5.71 | |
Net Debt/EBITDA |
4.27 | 7.25 | 5.63 | 3.24 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.67 | 0.77 | 1.11 | 0.85 | |
Capex/Depreciation |
0.00 | 0.01 | 0.02 | 0.03 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.26) | (1.20) | (1.37) | (1.53) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.26) | (1.20) | (1.37) | (1.53) | |
Cash per Share |
8.47 | 12.31 | 7.41 | 6.08 | |
Shareholders Equity per Share |
7.49 | 11.08 | 6.75 | 5.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.49 | 11.08 | 6.75 | 5.27 | |
Free Cash Flow |
(15.55) | (15.93) | (25.58) | (29.63) | |
Working Capital |
90.51 | 146.26 | 125.43 | 101.27 | |
Capital Expenditures |
— | (0.01) | (0.01) | (0.01) | |
Net Current Asset Value |
90.20 | 146.26 | 125.43 | 98.01 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
2.81 | 3.50 | 2.25 | 4.62 | |
Average Assets |
136.84 | 162.04 | 142.21 | 126.04 | |
Average Common Equity |
121.32 | 144.97 | 126.72 | 106.62 |
Columns are period end dates